Kaken, JP3207000005

Kaken stock: Kaken posts October 22 notice. Kaken stock has JPY 4,575 target benchmark.

Published on 10/23/2026 at 04:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kaken stock has a JPY 4,575 consensus target from four ratings. First-quarter revenue reached JPY 30.15 billion on August 7, 2026.

Notice and earnings dates

Kaken published an inquiry-form notice on October 22, 2026.
First-quarter revenue reached JPY 30.15 billion for the period ended June 30, 2026.
Kaken is scheduled to report its next results on November 9, 2026.

Kaken, JP3207000005, Illustration mit AI erstellt.

Kaken issued an October 22, 2026 notice about a temporary interruption to its inquiry form, while a four-rating consensus target of JPY 4,575 remains the clearest market reference for Kaken stock. The notice appears on Kaken Pharmaceutical, and Barron's lists the JPY 4,575 average target from four ratings as of October 9, 2026.

October notice keeps attention on execution

The company notice is operational rather than a change to earnings guidance. It matters because Kaken is moving through a recovery year after fiscal 2026 revenue fell to JPY 76.87 billion and operating profit turned negative at JPY 899 million, according to Investing.com.

What does JPY 8.44 billion mean?

Kaken's first-quarter results offer the more important operating signal. For the quarter ended June 30, 2026, revenue was JPY 30.15 billion and net income was JPY 8.44 billion, figures reported on August 7, 2026 by Investing.com. The result contrasts with the fiscal 2026 operating loss and gives the JPY 89.90 billion full-year sales guidance a measurable starting point.

Three dated steps for Kaken

In March 2026, Kaken received orphan-drug designation for KP-001, according to Quartr. On August 7, 2026, the company reported JPY 30.15 billion in first-quarter revenue and JPY 8.44 billion in net income. On October 22, 2026, Kaken published the inquiry-form notice.

Two dates shape the next check

The next scheduled reporting date is November 9, 2026, according to Investing.com. Barron's lists March 30, 2027 as the ex-dividend date, giving investors a second dated event beyond the earnings calendar.

Tokyo price and valuation context

Kaken was last quoted at JPY 3,870.00 on the Tokyo Stock Exchange on October 23, 2026 at 11:27 a.m. JST. Its 52-week range was JPY 3,540.00 to JPY 4,445.00, and its market capitalization was JPY 146.6 billion on the same date. The JPY 4,575.00 consensus target therefore sits above the Tokyo quotation, while the next results will test whether first-quarter profitability can support the full-year sales outlook.